Yuqiang Wang Selected Research

Enzymes

12/2017	A Rhodium(III) Complex as an Inhibitor of Neural Precursor Cell Expressed, Developmentally Down-Regulated 8-Activating Enzyme with in Vivo Activity against Inflammatory Bowel Disease.
4/2017	Neuroprotective Effects and Mechanisms of Action of Multifunctional Agents Targeting Free Radicals, Monoamine Oxidase B and Cholinesterase in Parkinson's Disease Model.
5/2016	A novel agent exerts antitumor activity in breast cancer cells by targeting mitochondrial complex II.
1/2001	Synthesis and preliminary cytotoxicity study of a cephalosporin-CC-1065 analogue prodrug.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuqiang Wang Research Topics

Disease

15	Parkinson Disease (Parkinson's Disease) 11/2021 - 07/2006
14	Ischemic Stroke 12/2019 - 10/2008
12	Neoplasms (Cancer) 01/2022 - 01/2001
11	Alzheimer Disease (Alzheimer's Disease) 07/2021 - 07/2006
10	Stroke (Strokes) 12/2019 - 10/2008
7	Myocardial Ischemia (Ischemic Heart Diseases) 02/2021 - 09/2013
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 07/2015
6	Inflammation (Inflammations) 12/2018 - 06/2015
4	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2016
4	Leukemia 12/2015 - 01/2001
3	Hypertension (High Blood Pressure) 01/2022 - 01/2012
3	Colitis 01/2020 - 01/2016
3	Pain (Aches) 02/2019 - 09/2014
3	Cerebral Infarction 01/2018 - 10/2015
3	Infarction (Infarctions) 01/2018 - 11/2016
3	Myocardial Infarction 01/2018 - 06/2015
3	Mitochondrial Diseases (Mitochondrial Disease) 04/2017 - 05/2016
3	Leukemia L1210 01/2012 - 10/2005
2	Fibrosis (Cirrhosis) 01/2022 - 01/2021
2	Cognitive Dysfunction 07/2021 - 01/2017
2	Reperfusion Injury 02/2021 - 09/2017
2	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 12/2019
2	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2019 - 11/2016
2	Neuralgia (Stump Neuralgia) 02/2019 - 01/2019
2	Spinal Cord Injuries (Spinal Cord Injury) 02/2019 - 01/2019
2	Acute Lung Injury 01/2019 - 06/2014
2	Body Weight (Weight, Body) 01/2019 - 10/2010
2	Intracranial Vasospasm 01/2019 - 01/2019
2	Cardiotoxicity 01/2019 - 01/2016
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2017 - 01/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2017 - 08/2015
2	Hypoxia (Hypoxemia) 09/2017 - 01/2017
2	Wounds and Injuries (Trauma) 05/2017 - 01/2017
2	Neuroblastoma 01/2017 - 10/2016
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 02/2016 - 10/2015
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Anemia 09/2021
1	Kyphosis 04/2021
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2021
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021
1	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2021
1	Disease Progression 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021

Drug/Important Bio-Agent (IBA)

16	Neuroprotective AgentsIBA 11/2021 - 10/2008
15	tetramethylpyrazineIBA 07/2021 - 06/2011
14	Pharmaceutical PreparationsIBA 07/2021 - 01/2001
10	tetramethylpyrazine nitroneIBA 01/2021 - 08/2012
10	Free RadicalsIBA 01/2019 - 10/2008
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2015
7	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021 - 07/2006
7	3,4-dihydroxyphenyllactic acidIBA 01/2019 - 06/2015
7	Thymidine Monophosphate (TMP)IBA 01/2019 - 10/2008
6	DT-010IBA 02/2021 - 01/2016
6	Memantine (Namenda)FDA Link 01/2021 - 07/2006
6	Therapeutic UsesIBA 01/2021 - 08/2012
6	andrographolideIBA 01/2020 - 07/2009
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 06/2006
5	Ephrin-A5 (AL-1)IBA 01/2020 - 07/2014
4	NitratesIBA 01/2021 - 01/2017
4	CalciumIBA 07/2020 - 01/2014
4	EnzymesIBA 12/2017 - 01/2001
3	N-Methylaspartate (NMDA)IBA 01/2021 - 01/2019
3	Glutamic Acid (Glutamate)FDA Link 07/2020 - 01/2018
3	Biological ProductsIBA 12/2019 - 10/2016
3	Monoamine Oxidase (MAO)IBA 11/2017 - 01/2017
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 06/2015
3	ProdrugsIBA 07/2008 - 01/2001
3	CC 1065IBA 04/2003 - 01/2001
2	VimentinIBA 01/2022 - 11/2016
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 01/2002
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020 - 10/2019
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020 - 11/2018
2	ProteomeIBA 06/2019 - 02/2015
2	dehydrocorybulbineIBA 02/2019 - 01/2019
2	Purinergic P2X4 ReceptorsIBA 02/2019 - 01/2019
2	Trinitrobenzenesulfonic AcidIBA 01/2019 - 01/2016
2	LipopolysaccharidesIBA 01/2019 - 06/2014
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2019 - 10/2016
2	MEF2 Transcription FactorsIBA 11/2018 - 11/2017
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 11/2017 - 07/2014
2	Cholinesterases (Cholinesterase)IBA 04/2017 - 01/2017
2	Dopamine (Intropin)FDA LinkGeneric 01/2017 - 07/2014
2	chrysinIBA 07/2016 - 07/2015
2	AntioxidantsIBA 01/2016 - 07/2015
2	Peptides (Polypeptides)IBA 10/2015 - 02/2015
2	Amlodipine (Norvasc)FDA LinkGeneric 09/2014 - 09/2013
2	homocamptothecinIBA 01/2012 - 10/2005
1	Valsartan (Vals)FDA Link 01/2022
1	AnthracyclinesIBA 01/2022
1	CollagenIBA 01/2022
1	polydatinIBA 11/2021
1	Biomarkers (Surrogate Marker)IBA 09/2021
1	Ligases (Synthetase)IBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021

Therapy/Procedure

15	Therapeutics 02/2021 - 01/2001
1	Operative Time 04/2021
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021
1	Percutaneous Coronary Intervention 01/2021
1	Denervation 01/2021
1	Transcatheter Aortic Valve Replacement 01/2021